Search Results - "Home, P.D"

Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL versus insulin glargine 100 U/mL in insulin- naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial by Bolli, G.B, Riddle, M.C, Bergenstal, R.M, Wardecki, M, Goyeau, H, Home, P.D

“…Abstract Aim To explore if efficacy and safety findings for insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100), observed over…”
Get full text

A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetes by Hall, G.C, McMahon, A.D, Dain, M.-P, Home, P.D

“…Abstract Aims We investigated whether differences in duration of first insulin use in type 2 diabetes remain after adjustment for potential confounders, and…”
Get full text

Short and Long-Term Cost-Effectiveness of Switching Therapy from NPH Insulin to Insulin Detemir in People with Type 2 Diabetes by Home, P.D, Malek, R, Gálvez, G.G, Hammerby, E, Nikolajsen, A, Henriksen, O, Andersen, M.F.B

Get full text

Short And Long-Term Cost-Effectiveness Of Starting Insulin Detemir In Insulin-Naïve People With Type-2 Diabetes by Home, P.D, Gálvez, G.G, Malek, R, Hammerby, E, Nikolajsen, A, Andersen, M.F.B, Henriksen, O

Get full text

Short And Long-Term Cost-Effectiveness Of Starting Biphasic Insulin Aspart 30 In Insulin-Naïve People With Type-2 Diabetes by Home, P.D, Soewondo, P, Hussein, Z, Shafie, A.A, AlRaddady, K, Baadbad, R, Hammerby, E, Nikolajsen, A, M.F.B, Andersen, Henriksen, O

Get full text

Short And Long-Term Cost-Effectiveness Of Switching Therapy From Insulin Glargine To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes In Saudi Arabia And India by Home, P.D, Soewondo, P, Shafie, A.A, AlRaddady, K, Baadbad, R, Hammerby, E, Nikolajsen, A, M.F.B., Andersen, Henriksen, O

Get full text

Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes by Home, P.D, Soewondo, P, Hussein, Z, Shafie, A.A, AlRaddady, K, Baadbad, R, Hammerby, E, Nikolajsen, A, Andersen, M.F.B, Henriksen, O

Get full text

The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes by Gallagher, A, Butler, T.J, Home, P.D

“…Abstract The abnormal glucose tolerance of Type 2 diabetes is characterized by post-prandial hyperglycaemia. We aimed to examine whether the restoration of a…”
Get full text

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial by Home, Philip D, Prof, Pocock, Stuart J, Prof, Beck-Nielsen, Henning, Prof, Curtis, Paula S, PhD, Gomis, Ramon, Prof, Hanefeld, Markolf, Prof, Jones, Nigel P, MA, Komajda, Michel, Prof, McMurray, John JV, Prof

“…Summary Background Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood glucose in people…”
Get full text

Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine by Home, P.D, Fritsche, A, Schinzel, S, Massi-Benedetti, M

“…Aim: To estimate absolute and relative incidence rates of hypoglycaemia when using once-daily evening or morning regimens of insulin glargine (glargine) versus…”
Get full text

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial by Bolli, G.B., Riddle, M.C., Bergenstal, R.M., Wardecki, M., Goyeau, H., Home, P.D.

“…To explore if efficacy and safety findings for insulin glargine 300U/mL (Gla-300) versus insulin glargine 100U/mL (Gla-100), observed over 6 months in…”
Get full text

Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events by Riddle, M.C., Bolli, G.B., Avogaro, A., Gimenez Álvarez, M., Merino-Trigo, A., Boëlle-Le Corfec, E., Home, P.D.

“…To describe in type 2 diabetes the 24-hour distribution of hypoglycaemia and compare the frequency of nocturnal events based on a predefined nocturnal window…”
Get full text

Hepatic dysfunction and insulin insensitivity in type 2 diabetes mellitus: a critical target for insulin-sensitizing agents by Home, P.D, Pacini, G

“…The liver plays an essential role in maintaining glucose homeostasis, which includes insulin-mediated processes such as hepatic glucose output (HGO) and…”
Get full text

PDB15 - Short and Long-Term Cost-Effectiveness of Switching Therapy from NPH Insulin to Insulin Detemir in People with Type 2 Diabetes by Home, P.D., Malek, R., Gálvez, G.G., Hammerby, E., Nikolajsen, A., Henriksen, O., Andersen, M.F.B.

Get full text

PDB46 - Short And Long-Term Cost-Effectiveness Of Starting Insulin Detemir In Insulin-Naïve People With Type-2 Diabetes by Home, P.D., Gálvez, G.G., Malek, R., Hammerby, E., Nikolajsen, A., Andersen, M.F.B., Henriksen, O.

Get full text

PDB48 - Short And Long-Term Cost-Effectiveness Of Switching Therapy From Insulin Glargine To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes In Saudi Arabia And India by Home, P.D., Soewondo, P., Shafie, A.A., AlRaddady, K., Baadbad, R., Hammerby, E., Nikolajsen, A., M.F.B., Andersen, Henriksen, O.

Get full text

PDB49 - Short And Long-Term Cost-Effectiveness Of Starting Biphasic Insulin Aspart 30 In Insulin-Naïve People With Type-2 Diabetes by Home, P.D., Soewondo, P., Hussein, Z., Shafie, A.A., AlRaddady, K., Baadbad, R., Hammerby, E., Nikolajsen, A., M.F.B, Andersen, Henriksen, O.

Get full text

PDB47 - Short And Long-Term Cost-Effectiveness Of Switching Therapy From Biphasic Human Insulin 30 To Biphasic Insulin Aspart 30 In People With Type-2 Diabetes by Home, P.D., Soewondo, P., Hussein, Z., Shafie, A.A., AlRaddady, K., Baadbad, R., Hammerby, E., Nikolajsen, A., Andersen, M.F.B., Henriksen, O.

Get full text

The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes by Gallagher, A., Home, P.D.

“…A variety of abnormalities of metabolic, haemostatic and endothelial markers are associated with Type 2 diabetes. Evidence suggests that poor post-prandial…”
Get full text

Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes by Home, P.D., Hallgren, P., Usadel, K.H., Sane, T., Faber, J., Grill, V., Friberg, H.H.

“…Insulin aspart has been shown, in medium-term studies, to achieve reductions in HbA 1c without increasing the risk of major hypoglycaemia compared with…”
Get full text